SWM

SeaCrest Wealth Management Portfolio holdings

AUM $921M
1-Year Return 24.42%
This Quarter Return
+13.84%
1 Year Return
+24.42%
3 Year Return
+101.15%
5 Year Return
+173.95%
10 Year Return
AUM
$583M
AUM Growth
+$97.9M
Cap. Flow
+$37.6M
Cap. Flow %
6.45%
Top 10 Hldgs %
20.09%
Holding
2,337
New
86
Increased
544
Reduced
552
Closed
115

Sector Composition

1 Technology 13.43%
2 Communication Services 11.24%
3 Financials 11.03%
4 Healthcare 7.62%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VIAV icon
1901
Viavi Solutions
VIAV
$2.6B
$2K ﹤0.01%
201
-143
-42% -$1.42K
VNO icon
1902
Vornado Realty Trust
VNO
$7.93B
$2K ﹤0.01%
35
WAL icon
1903
Western Alliance Bancorporation
WAL
$10B
$2K ﹤0.01%
50
WTFC icon
1904
Wintrust Financial
WTFC
$9.34B
$2K ﹤0.01%
37
APOG icon
1905
Apogee Enterprises
APOG
$939M
$2K ﹤0.01%
+41
New +$2K
ARWR icon
1906
Arrowhead Research
ARWR
$4.02B
$2K ﹤0.01%
100
-75
-43% -$1.5K
ASGN icon
1907
ASGN Inc
ASGN
$2.32B
$2K ﹤0.01%
34
ATR icon
1908
AptarGroup
ATR
$9.13B
$2K ﹤0.01%
17
BLDR icon
1909
Builders FirstSource
BLDR
$16.5B
$2K ﹤0.01%
122
BLKB icon
1910
Blackbaud
BLKB
$3.23B
$2K ﹤0.01%
30
BLMN icon
1911
Bloomin' Brands
BLMN
$605M
$2K ﹤0.01%
102
BRO icon
1912
Brown & Brown
BRO
$31.3B
$2K ﹤0.01%
60
BWZ icon
1913
SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$375M
$2K ﹤0.01%
75
CARS icon
1914
Cars.com
CARS
$835M
$2K ﹤0.01%
101
CASY icon
1915
Casey's General Stores
CASY
$18.8B
$2K ﹤0.01%
12
CCK icon
1916
Crown Holdings
CCK
$11B
$2K ﹤0.01%
44
CHX
1917
DELISTED
ChampionX
CHX
$2K ﹤0.01%
50
CIEN icon
1918
Ciena
CIEN
$16.5B
$2K ﹤0.01%
64
CNQ icon
1919
Canadian Natural Resources
CNQ
$63.2B
$2K ﹤0.01%
141
CSL icon
1920
Carlisle Companies
CSL
$16.9B
$2K ﹤0.01%
18
CVV icon
1921
CVD Equipment Corp
CVV
$19.1M
$2K ﹤0.01%
500
DBRG icon
1922
DigitalBridge
DBRG
$2.04B
$2K ﹤0.01%
85
DIOD icon
1923
Diodes
DIOD
$2.46B
$2K ﹤0.01%
59
+48
+436% +$1.63K
ERH
1924
Allspring Utilities & High Income Fund
ERH
$106M
$2K ﹤0.01%
115
+2
+2% +$35
ESPR icon
1925
Esperion Therapeutics
ESPR
$540M
$2K ﹤0.01%
50